The buddy benefit: increasing the effectiveness of an employee-targeted weight-loss program
If youve already been considering GLP-1 medications for usage in treating obesity or diabetes symptoms, ask your care team how they might help support your substance abuse issues as well
This study suggests oral semaglutide may help reduce heavy and harmful drinking, even in people who are not trying to quit alcohol entirely, said Joseph Schacht, PhD, associate professor at the CU Anschutz School of Medicine, in the announcement
Do not freeze a mixed vial
The questions that Phase 3 will need to answer and that regulators will scrutinize closely include cardiovascular outcomes over extended periods, liver function changes beyond the 48-week window, potential interactions with other metabolic agents, and safety in populations not well-represented in Phase 2
Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells